These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 17239347)
1. Bone marrow-derived osteoblast progenitor cells in circulating blood contribute to ectopic bone formation in mice. Otsuru S; Tamai K; Yamazaki T; Yoshikawa H; Kaneda Y Biochem Biophys Res Commun; 2007 Mar; 354(2):453-8. PubMed ID: 17239347 [TBL] [Abstract][Full Text] [Related]
2. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway. Otsuru S; Tamai K; Yamazaki T; Yoshikawa H; Kaneda Y Stem Cells; 2008 Jan; 26(1):223-34. PubMed ID: 17932420 [TBL] [Abstract][Full Text] [Related]
3. Controlled release of bone morphogenetic protein-2 enhances recruitment of osteogenic progenitor cells for de novo generation of bone tissue. Kimura Y; Miyazaki N; Hayashi N; Otsuru S; Tamai K; Kaneda Y; Tabata Y Tissue Eng Part A; 2010 Apr; 16(4):1263-70. PubMed ID: 19886805 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical localization of bone morphogenetic proteins (BMPs) 2, 4, 6, and 7 during induced heterotopic bone formation. McCullough KA; Waits CA; Garimella R; Tague SE; Sipe JB; Anderson HC J Orthop Res; 2007 Apr; 25(4):465-72. PubMed ID: 17262821 [TBL] [Abstract][Full Text] [Related]
5. Low dose fibroblast growth factor-2 (FGF-2) enhances bone morphogenetic protein-2 (BMP-2)-induced ectopic bone formation in mice. Nakamura Y; Tensho K; Nakaya H; Nawata M; Okabe T; Wakitani S Bone; 2005 Mar; 36(3):399-407. PubMed ID: 15777655 [TBL] [Abstract][Full Text] [Related]
6. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats. Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149 [TBL] [Abstract][Full Text] [Related]
7. Bone formation following transplantation of genetically modified primary bone marrow stromal cells. Sugiyama O; Orimo H; Suzuki S; Yamashita K; Ito H; Shimada T J Orthop Res; 2003 Jul; 21(4):630-7. PubMed ID: 12798062 [TBL] [Abstract][Full Text] [Related]
8. The nucleocytoplasmic shuttling protein CIZ reduces adult bone mass by inhibiting bone morphogenetic protein-induced bone formation. Morinobu M; Nakamoto T; Hino K; Tsuji K; Shen ZJ; Nakashima K; Nifuji A; Yamamoto H; Hirai H; Noda M J Exp Med; 2005 Mar; 201(6):961-70. PubMed ID: 15781586 [TBL] [Abstract][Full Text] [Related]
9. Mixing conditions for cell scaffolds affect the bone formation induced by bone engineering with human bone marrow stromal cells, beta-tricalcium phosphate granules, and rhBMP-2. Uchida M; Agata H; Sagara H; Shinohara Y; Kagami H; Asahina I J Biomed Mater Res A; 2009 Oct; 91(1):84-91. PubMed ID: 18767063 [TBL] [Abstract][Full Text] [Related]
10. Regulation of BMP-induced ectopic bone formation by Ahsg. Rittenberg B; Partridge E; Baker G; Clokie C; Zohar R; Dennis JW; Tenenbaum HC J Orthop Res; 2005 May; 23(3):653-62. PubMed ID: 15885488 [TBL] [Abstract][Full Text] [Related]
11. Ectopic osteogenesis by ex vivo gene therapy using beta tricalcium phosphate as a carrier. Han D; Sun X; Zhang X; Tang T; Dai K Connect Tissue Res; 2008; 49(5):343-50. PubMed ID: 18991087 [TBL] [Abstract][Full Text] [Related]
12. BMP-2 regulation of PTHrP and osteoclastogenic factors during osteoblast differentiation of C2C12 cells. Susperregui AR; Viñals F; Ho PW; Gillespie MT; Martin TJ; Ventura F J Cell Physiol; 2008 Jul; 216(1):144-52. PubMed ID: 18247361 [TBL] [Abstract][Full Text] [Related]
14. New bone formation by murine osteoprogenitor cells cultured on corticocancellous allograft bone. Nelson ER; Huang Z; Ma T; Lindsey D; Jacobs C; Smith RL; Goodman SB J Orthop Res; 2008 Dec; 26(12):1660-4. PubMed ID: 18524004 [TBL] [Abstract][Full Text] [Related]
15. [Activation of auto-mesenchymal stem cells of skeletal muscle by bone morphogenetic protein for rescuing bone marrow failure]. Chu JX; Zhao JM; Ding SL; Xu SC; Liu AR; Wang SP Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Jun; 24(3):272-5. PubMed ID: 12905633 [TBL] [Abstract][Full Text] [Related]
16. Osteogenic differentiation of rabbit mesenchymal stem cells in thermo-reversible hydrogel constructs containing hydroxyapatite and bone morphogenic protein-2 (BMP-2). Na K; Kim SW; Sun BK; Woo DG; Yang HN; Chung HM; Park KH Biomaterials; 2007 Jun; 28(16):2631-7. PubMed ID: 17331575 [TBL] [Abstract][Full Text] [Related]
17. Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery. Jeon O; Song SJ; Yang HS; Bhang SH; Kang SW; Sung MA; Lee JH; Kim BS Biochem Biophys Res Commun; 2008 May; 369(2):774-80. PubMed ID: 18313401 [TBL] [Abstract][Full Text] [Related]
18. Cystatin C stimulates the differentiation of mouse osteoblastic cells and bone formation. Danjo A; Yamaza T; Kido MA; Shimohira D; Tsukuba T; Kagiya T; Yamashita Y; Nishijima K; Masuko S; Goto M; Tanaka T Biochem Biophys Res Commun; 2007 Aug; 360(1):199-204. PubMed ID: 17592728 [TBL] [Abstract][Full Text] [Related]
19. Bone-marrow-derived cell differentiation into microglia: a study in a progressive mouse model of Parkinson's disease. Rodriguez M; Alvarez-Erviti L; Blesa FJ; Rodríguez-Oroz MC; Arina A; Melero I; Ramos LI; Obeso JA Neurobiol Dis; 2007 Dec; 28(3):316-25. PubMed ID: 17897835 [TBL] [Abstract][Full Text] [Related]
20. The effect of combined application of TGFbeta-1, BMP-2, and COLLOSS E on the development of bone marrow derived osteoblast-like cells in vitro. van der Zande M; Walboomers XF; Briest A; Springer M; Alava JI; Jansen JA J Biomed Mater Res A; 2008 Sep; 86(3):788-95. PubMed ID: 18041723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]